Lisata Therapeutics agrees to Kuva Labs buyout at $4 per share
Lisata Therapeutics agrees to Kuva Labs buyout at $4 per share
Lisata Therapeutics agrees to Kuva Labs buyout at $4 per share
Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.